Skip to main content

Table 1 Baseline clinical and demographic characteristics of study population

From: Association of the magnitude of the difference in blood pressure between office and ambulatory measurements with blood pressure variability in untreated individuals

Variables

 

n

296

Sex

 Male, n (%)

134 (45.3)

 Female, n (%)

162 (54.7)

Age, years

51.6 ± 10.2

Body mass index, kg/m2

25.3 ± 3.4

eGFR, ml/min/1.73 m2

99.2 ± 12.4

spot urine ACR

9.3 ± 6.6

LDL cholesterol, mg/dL

132.8 ± 32.5

Fasting blood glucose, mg/dL

103.5 ± 19.9

HbA1C, %

5.7 ± 0.6

Diabetes, n (%)

36 (8.8)

Office hypertension, n (%)

207 (69.9)

Ambulatory daytime hypertension, n (%)

239 (80.7)

Office SBP, mmHg

140.5 ± 9.1

Office DBP, mmHg

91.1 ± 8.1

24-h ambulatory SBP, mmHg

133.3 ± 11.5

24-h ambulatory DBP, mmHg

88.2 ± 10.3

Daytime ambulatory SBP, mmHg

137.9 ± 12.3

Daytime ambulatory DBP, mmHg

92.0 ± 11.0

Nighttime ambulatory SBP, mmHg

124.7 ± 13.6

Nighttime ambulatory DBP, mmHg

81.0 ± 11.1

  1. eGFR Estimated glomerular filtration rate, ACR Albumin to creatinine ratio, LDL Low density lipoprotein, SBP systolic blood pressure, DBP Diastolic blood pressure
  2. The eGFR values were calculated using the 2009 CKD-Epidemiology creatinine equation. Systolic hypertension phenotype was defined by the level of office and ambulatory daytime systolic blood pressure